Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$2.7M
7 rounds on record
Latest round
Seed
Jun 2025 · 15 mo ago
Backers
1
Alamo Angels
The money's age
Due for its next round
15 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 7 Took on debt financing $75k · SEC Form D Feb 24 Certified Liquet Medical Receives Second FDA 510(k) Clearance for Versus Catheter · liquetmedical.com Jun 25, 2025 Raised a round Seed Dec 23, 2024 Raised a round Convertible Note $1.1M · SEC Form D Dec 10, 2024 Certified Liquet Medical Inc. Receives FDA 510(k) Clearance for Versus Catheter · liquetmedical.com Jun 26, 2024 Board appointment Liquet Medical Appoints Gabriele G. Niederauer as Chair of the Board of Directors · liquetmedical.com Dec 11, 2023 Raised a round Convertible Note $615k · SEC Form D Apr 5, 2023 Raised a round Convertible Note $405k · SEC Form D May 27, 2022 Raised a round Convertible Note $605k · SEC Form D Oct 8, 2021 Took on debt financing $550k · SEC Form D 2021 Founded
Funding rounds
RoundDateAmountInvestorsSource
Debt Financing Mar 2026 $75k — SEC Form D
Seed Jun 2025 — — ksn.com
Convertible Note Dec 2024 $1.1M — SEC Form D
Convertible Note Dec 2023 $615k — SEC Form D
Convertible Note Apr 2023 $405k — SEC Form D
Convertible Note May 2022 $605k — SEC Form D
Debt Financing Oct 2021 $550k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Liquet Medical Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
John SchindlerExecutive Officer, DirectorSEC Form D
Koren SchindlerExecutive OfficerSEC Form D
Derek HallExecutive Officer, DirectorSEC Form D
Paul SartoriDirectorSEC Form D
Paul SatoriExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
ThinkSonoVenture round $2.7M · 2 yr ago • 51-200 employees
ThinkSono Guidance enables any non-ultrasound trained healthcare professional to scan for blood clots (DVT). It reduces waiting times…
Samay2 roles
AI-powered solutions revolutionizing lung health with advanced diagnostics, predictive analytics, and personalized respiratory care for…
AESOPFounded 2019
Explore AESOP’s clinical decision intelligence, powered by 3.2 billion real-world medical records to support explainable, context-aware…
Compa SaaS Customer Agreement between Compa Technologies, Inc.Venture round $12.1M · 2 yr ago • Founded 2020 • 11-50 employees • 3 roles
Built to think like a comp expert—trained on your strategy and powered by Compa’s market data to guide every pay decision.
DELFI DiagnosticsVenture round $225M · 4 yr ago • Founded 2019 • 51-200 employees • 2 roles
FirstLook Lung is a blood-based test that helps identify lung cancer risk before or alongside LDCT, for USPSTF-eligible adults. From DELFI…
Protyon51-200 employees
Supporting the clinical decision-making process to choose the best available therapy for patients.

Overview

Treat Beyond the Clot.. Real-time data to guide clinical decisions when treating blood clots in the lungs.

News

Blog 8 months ago
Liquet Medical Receives Second FDA 510(k) Clearance for Versus Catheter
Expands Hemodynamic-Guided Thrombolysis (HGT) platform and unlocks new interventional segment Charlottesville, VA - February 24, 2026 Liquet Medical Inc., a pioneering medical device company committed to advancing patient care through innovative technolog
Read more
Report
Blog 2 years ago
Liquet Medical Inc. Receives FDA 510(k) Clearance for Versus Catheter
Charlottesville, VA - December 10, 2024 Hemodynamic-Guided Thromobolysis (HGT) allows physicians to personalize the treatment of blood clots in the lungs utilizing real-time pulmonary artery pressure Liquet Medical Inc., a pioneering medical device compan
Read more
Report
Blog 2 years ago
Liquet Medical Appoints Gabriele G. Niederauer as Chair of the Board of Directors
Charlottesville, VA - June 26, 2024 Liquet Medical, a private medical technology company focused on treating blood clots in the lungs using a localized drug-delivery catheter, today announced that the Board of Directors has appointed Gabriele G. Niederaue
Read more
Report
Blog 3 years ago
VIPC's Virginia Venture Partners Invests in Liquet Medical to Support the Transformation of Vascular Disease Treatment
Company is developing personalized therapy for the treatment of blood clots in the lungs through an intelligent, localized drug-delivery catheter. RICHMOND, VIRGINIA, UNITED STATES, July 6, 2023 -- Virginia Venture Partners, the equity investment program
Read more
Report
Award 3 years ago
VIPC Awards Commonwealth Commercialization Fund Grant to Liquet Medical
CCF grants support startups, critical early technology testing and market validation efforts RICHMOND, VIRGNIA, UNITED STATES, March 9, 2023 - The Virginia Innovation Partnership Corporation (VIPC), the nonprofit operations arm of the Virginia Innovation
Read more
Report
Award 4 years ago
MedTech Innovator Announces Top 50 Startups Selected for the 2022 Cohort in Tenth Year of World's Largest MedTech Accelerator Program
LOS ANGELES - MedTech Innovator, the world's largest accelerator of medical technology companies, today announced the 50 companies selected to participate in the organization's flagship four-month Accelerator program, featuring medical device, diagnostic,
Read more
Report
Blog 5 years ago
Sanford Doctor's Device Simplifies Lung Blood Clot Treatment
Sanford Health vascular surgeon Dr. Patrick Kelly has invented a unique device to transform treatment of blood clots in the lungs that kill as many as 100,000 Americans each year. Kelly licensed his pulmonary embolism, or PE, catheter to startup company L
Read more
Report

People

John Schindler
Executive Officer, Director
Koren Schindler
Executive Officer
Derek Hall
Executive Officer, Director
Paul Sartori
Director
Paul Satori
Executive Officer, Director
Gary Cupit
Director
Gabriele Niederauer
Director
Mary Byron
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Glen Allen United States
HQ
Board of Directors
5619 Country Hills Ln, Glen Allen, VA 23059
company site

Financials

Total raised
$3.3M
Latest round
Debt Financing
Funding rounds
7
Funding rounds
Round Announced Amount
Debt Financing 2026 $75k Details
Seed 2025 — Details
Convertible Note 2024 $1.1M Details
Convertible Note 2023 $615k Details
Convertible Note 2023 $405k Details
Convertible Note 2022 $605k Details
Debt Financing 2021 $550k Details